PESAB06 Cryptococcus qPCR assays: the future for routine mycology labs and clinical trials dealing with HIV-associated cryptococcosisPoster exhibitionDiagnostics of co-infections and co-morbidities
PESAB07 Antenatal systemic inflammation and mortality of children born to mothers with HIV in rural ZimbabwePoster exhibitionBiomarkers for the prediction of morbidity and mortality
PESAB08 Viral suppression among adults with HIV receiving dolutegravir-based antiretroviral therapy and 3HP in Kampala, UgandaPoster exhibitionTuberculosis: Prevention, diagnosis, treatment
PESAB09 Pharmacokinetic and 48 week efficacy of once-daily vs twice-daily dolutegravir among patients with human immunodeficiency virus/tuberculosis coinfection receiving rifampicin based tuberculosis therapy: a randomized control trialPoster exhibitionTuberculosis: Prevention, diagnosis, treatment
PESAB10 Sitafloxacin therapy for mycoplasma genitalium in men who have sex with menPoster exhibitionSTIs (including HPV)
PESAB11 The acceptability of the AMBITION treatment regimen for HIV-associated cryptococcal meningitis: findings from a qualitative study of patients and providers in Botswana and UgandaPoster exhibitionOpportunistic infections (excluding TB): Bacterial, non-TB mycobacterial, viral and parasitic infections
PESAB12 Efficacy of cefixime for the treatment of Neisseria gonorrhoeae infection at three anatomic sites: a systematic review and meta-analysisPoster exhibitionSTIs (including HPV)
PESAB13 Cumulative HIV-1 viremia is associated with multimorbidity among U.S. women with HIVPoster exhibitionCardiovascular disease
PESAC01 Prevalence and individual and community-level risk factors of advanced HIV disease among people living with HIV from nine African countriesPoster exhibitionEpidemiology of HIV in the general population
PESAC02 High transmitted drug resistance in Brazil: unprecedented levels of INSTI resistancePoster exhibitionEpidemiology of HIV in the general population
2321 - 2330 of 2485 items